Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...
Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...
Amytrx and Amarex Clinical Research, LLC, an NSF company, announced they are initiating the Phase II clinical trial on atopic dermatitis (AD) using Amytrx's...
Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company"), announced that the first subject has been dosed in the Company's Phase 1a single ascending dose...
Axon Therapies, a private company focused on addressing a root cause of heart failure, announced positive early results from a roll-in cohort for their...
